“Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies.” S.A. Reddy, J. Newman, O.C. Leavy, et al. Eur Respir J 2024; 64: 2301742.

Extract

This article was originally published with incomplete author disclosures. The statement for M.R. Toshner was omitted and should have been presented as follows:

This article was originally published with incomplete author disclosures. The statement for M.R. Toshner was omitted and should have been presented as follows:

M.R. Toshner reports support for the present study from NIHR Cambridge BRC and MRC, consultancy fees from Jansen, Apollo Therapeutics and Merck, support for attending meetings from GSK and Jansen, and participation on a data safety monitoring board or advisory board with ComCov and FluCov.

The article has been corrected and republished online.